Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | DS-9606a |
Synonyms | |
Therapy Description |
DS-9606a is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody targeting CLDN6 linked to an undisclosed cytotoxic agent, with potential anti-tumor activity in CLDN6-expressing tumor cells (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
DS-9606a | DS9606a|DS 9606a|DS9606|DS 9606|DS-9606 | CLDN6 Antibody 7 | DS-9606a is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody targeting CLDN6 linked to an undisclosed cytotoxic agent, with potential anti-tumor activity in CLDN6-expressing tumor cells (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05394675 | Phase I | DS-9606a | A Study of DS-9606a in Patients With Advanced Solid Tumors | Recruiting | USA | GBR | 0 |